Evolics Bio Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-07-2024
- Paid Up Capital ₹ 0.10 M
as on 18-07-2024
- Company Age 5 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.60 M
as on 18-07-2024
- Revenue 9.93%
(FY 2023)
- Profit 146.13%
(FY 2023)
- Ebitda -38.78%
(FY 2023)
- Net Worth 38.29%
(FY 2023)
- Total Assets 56.64%
(FY 2023)
About Evolics Bio
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.60 M.
Susanta Paul and Debarati Paul serve as directors at the Company.
- CIN/LLPIN
U24239DL2019PTC353611
- Company No.
353611
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Aug 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Evolics Bio?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Susanta Paul  | Director | 07-Aug-2019 | Current |
| Debarati Paul | Director | 12-Oct-2021 | Current |
Financial Performance of Evolics Bio.
Evolics Bio Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.93% increase. The company also saw a substantial improvement in profitability, with a 146.13% increase in profit. The company's net worth Soared by an impressive increase of 38.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Evolics Bio?
In 2023, Evolics Bio had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Symbio Scientific Private LimitedActive 13 years 10 daysSusanta Paul and Debarati Paul are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 18 Feb 2020 | ₹2.60 M | Open |
How Many Employees Work at Evolics Bio?
Unlock and access historical data on people associated with Evolics Bio, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Evolics Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evolics Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
